3D Bioprinting Market 2024 - By Industry Analysis, Future Prediction, Business Overview And Forecast To 2033

The new report published by The Business Research Company, titled ""3D Bioprinting Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the 3d bioprinting market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.9 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The 3d bioprinting market size is expected to see exponential growth in the next few years. It will grow to $4.15 billion in 2028 at a compound annual growth rate (CAGR) of 21.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=5341&type=smp

Increased Government And Private Funding Fuels The Growth Of 3D Bioprinting Market
Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2021, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 in June 2020 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration.

Next-Generation Of Bioprinters For Enhanced Precision
Major companies operating in the 3D bioprinting market are introducing next-generation bioprinters that are cost-effective such as the BIO MDX Series to increase precision. The BIO MDX Series is the latest generation of bioprinters, designed for high-throughput fabrication and precision 3D bioprinting in biomedical manufacturing. For instance, in March 2021, Cognex Corporation, a Sweden-based bioconvergence company launched the BIO MDX Series, a next-generation of bioprinters optimized for high-throughput biofabrication and precision 3D bioprinting in biomedical manufacturing. This development comes as 3D bioprinting becomes a preferred method for researchers in tissue engineering and regenerative medicine, highlighting the need for enhanced automation, precision, and reproducibility. The BIO MDX series, with up to six printheads and integrated nanoliter and picoliter dispensing channels, caters to advanced cell-based technologies.

The 3d bioprinting market covered in this report is segmented -

1) By Component: 3D Bioprinters, Bioinks
2) By Material: Living Cells, Hydrogels, Extracellular Matrices, Other Materials
3) By Application: Research Applications, Clinical Application, Other Applications
4) By End User: Research Organization And Academic Institutes, Biopharmaceuticals Companies, Hospitals, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=5341&type=discount

Major companies operating in the 3d bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

Contents of the report:
1. Executive Summary
2. 3D Bioprinting Market Report Structure
3. 3D Bioprinting Market Trends And Strategies
4. 3D Bioprinting Market - Macro Economic Scenario
5. 3D Bioprinting Market Size And Growth
…..
27. 3D Bioprinting Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/3d-bioprinting-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.